Your session is about to expire
← Back to Search
Pioglitazone for Rheumatoid Arthritis
Study Summary
This trial will test if a medication called metformin, which is used to treat insulin resistance, can help improve muscle strength in patients with RA.
- Rheumatoid Arthritis
- Insulin Resistance
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has Pioglitazone obtained regulatory approval from the FDA?
"Due to limited data supporting safety and efficacy, Pioglitazone was assigned a score of 1."
Does this trial encompass individuals aged 40 or above?
"Eligibility requirements for this clinical trial restrict the age range of applicants to between 35 and 65 years old. There are 77 studies available for minors, while those aged above 65 have access to 445 different trials."
May I have the privilege of participating in this research project?
"To be accepted into this medical trial, volunteers must demonstrate signs of insulin resistance and fall within a 35-65 year age range. A total of 36 individuals are required for the study."
What is the size of the sample population for this investigation?
"Yes, the clinical trial is indeed still recruiting. According to data available on clinicatrials.gov, it was initially posted in September 2015 and updated most recently in May 2022. A total of 36 patients are sought from a single location."
In what scenarios is Pioglitazone normally employed?
"Pioglitazone is the standard of care for diabetes, but it can also be beneficial in managing diabetic neuralgia and other conditions through dietary modifications and increased activity levels."
Are there other investigations utilizing Pioglitazone currently available?
"Currently, 31 clinical trials on Pioglitazone are underway with 4 of them situated in phase 3. While Lausanne, Vaud has several studies dedicated to this drug, 69 research centres have such investigations taking place."
Are there any remaining vacancies for participants in this medical experiment?
"Clinicaltrials.gov states that this research has been in active recruitment since its posting on September 1, 2015 and most recently updated on May 6th 2022."
Share this study with friends
Copy Link
Messenger